Current Edition


FDA chides Eli Lilly for second misleading ad in 2 months, this time for diabetes blockbuster Trulicity

After neatly wrapping up concerns over a series of Emgality ads last month, Eli Lilly is back in hot water with the FDA’s Office of …

Continue Reading →

Cannabidiol shows promise alongside conventional epilepsy medication in Lennox-Gastaut Syndrome

The use of medical cannabis to treat seizures has been in the news a lot this week due to the current case involving 12-year old …

Continue Reading →

ReCor Medical Announces Completion of RADIANCE-HTN SOLO Hypertension Study

ReCor Medical announced today randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study.  RADIANCE-HTN, ReCor’s study of its Paradise Renal …

Continue Reading →

CRF Health’s TrialMax Touch® Selected by Leading Specialty Pharmaceutical Company for Pediatric Rare Disease Phase II Study

CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, has been selected by a leading specialty …

Continue Reading →